phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Metformin and Ursodeoxycholic Acid Both Fail to Improve Long COVID Recovery in New Clinical Trial

A randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from long COVID symptoms, despite earlier evidence suggesting metformin could lower long-term risk when taken during acute infection.

March 2, 2026


March 12 2026

March 11 2026

March 10 2026

March 9 2026

March 8 2026

March 7 2026

March 6 2026

March 5 2026

March 4 2026

March 3 2026

March 2 2026

March 1 2026

February 28 2026

February 27 2026

February 26 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy